Literature DB >> 1680108

Aerobic exercise training in an AIDS risk group.

A LaPerriere1, M A Fletcher, M H Antoni, N G Klimas, G Ironson, N Schneiderman.   

Abstract

Increases in physical fitness are often associated with improvements in certain chronic diseases, such as hypertension and coronary heart disease. Recent evidence has shown that exercise also influences the neuroendocrine and immune systems, resulting in a potential to benefit those with chronic immunodeficiency diseases. Therefore, exercise may prove to have a profound impact on the management of the acquired immunodeficiency syndrome (AIDS). Our current work includes the investigation of the immunologic and stress-attenuating effects of an aerobic exercise training program for individuals at risk for AIDS. Upon completion of training, the subjects showed a significant increase in helper/inducer (CD4) cells and the inducer subset (CD45RA+CD4+) which activate suppressor/cytotoxic (CD8) cells. These increases, which average about 50 cells per cubic millimeter, are comparable to those observed in some studies of the AIDS drug comparable to those observed in some studies of the AIDS drug azidothymidine (AZT), but without the accompanying side effects. Also, individuals undergoing aerobic training reported no increases in anxiety and depression in response to notification of a positive HIV-1 serologic status. These findings taken together indicate that an aerobic exercise training program may enhance certain critical components of cellular immunity as well as acting as a buffer for the detrimental mood changes that typically accompany stress, thus providing a timely, promising behavioral approach to helping HIV-1-infected individuals.

Entities:  

Mesh:

Year:  1991        PMID: 1680108     DOI: 10.1055/s-2007-1024751

Source DB:  PubMed          Journal:  Int J Sports Med        ISSN: 0172-4622            Impact factor:   3.118


  14 in total

1.  HIV and aerobic exercise. Current recommendations.

Authors:  W W Stringer
Journal:  Sports Med       Date:  1999-12       Impact factor: 11.136

2.  Social cognitive and physical health determinants of exercise adherence for HIV-1 seropositive, early symptomatic men and women.

Authors:  R M Pavone; K F Burnett; A LaPerriere; F M Perna
Journal:  Int J Behav Med       Date:  1998

3.  Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population.

Authors:  C L Lox; E McAuley; R S Tucker
Journal:  Int J Behav Med       Date:  1996

Review 4.  Exercise and immune function. Recent developments.

Authors:  D C Nieman; B K Pedersen
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

Review 5.  Evaluating the Effectiveness of Physical Exercise Interventions in Persons Living With HIV: Overview of Systematic Reviews.

Authors:  Emiko Kamitani; Theresa Ann Sipe; Darrel H Higa; Mary M Mullins; Jesus Soares
Journal:  AIDS Educ Prev       Date:  2017-08

Review 6.  Exercise and human immunodeficiency virus (HIV-1) infection.

Authors:  D Lawless; C G Jackson; J E Greenleaf
Journal:  Sports Med       Date:  1995-04       Impact factor: 11.136

Review 7.  Human immunodeficiency virus infection, exercise and athletics.

Authors:  L H Calabrese; A LaPerriere
Journal:  Sports Med       Date:  1993-01       Impact factor: 11.136

8.  Aerobic fitness levels and validation of a non exercise VO2max prediction equation for HIV-infected patients on HAART.

Authors:  Katherine Sullivan; Cecilia M Shikuma; Dominic Chow; Elizabeth Cornelius; Rebecca K Romine; Rachel A Lindsey; Christopher D Stickley; Iris F Kimura; Ronald K Hetzler
Journal:  HIV Clin Trials       Date:  2014 Mar-Apr

Review 9.  Therapeutic impact of exercise on psychiatric diseases: guidelines for exercise testing and prescription.

Authors:  T Meyer; A Broocks
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

10.  Effectiveness of aerobic exercise for adults living with HIV: systematic review and meta-analysis using the Cochrane Collaboration protocol.

Authors:  Kelly K O'Brien; Anne-Marie Tynan; Stephanie A Nixon; Richard H Glazier
Journal:  BMC Infect Dis       Date:  2016-04-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.